{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:48:41Z","timestamp":1775695721767,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Technology Pillar Program","award":["2012BAI08B06"],"award-info":[{"award-number":["2012BAI08B06"]}]},{"name":"National High-Tech Research and Development Program of China","award":["2015AA20511"],"award-info":[{"award-number":["2015AA20511"]}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["NS040723"],"award-info":[{"award-number":["NS040723"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2013M542249"],"award-info":[{"award-number":["2013M542249"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.jneuroim.2015.10.005","type":"journal-article","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T19:08:17Z","timestamp":1445540897000},"page":"56-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["The poor recovery of neuromyelitis optica spectrum disorder is associated with a lower level of CXCL12 in the human brain"],"prefix":"10.1016","volume":"289","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0606-2478","authenticated-orcid":false,"given":"Hao","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaocai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaohui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanping","family":"Ai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quangang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2015.10.005_bb0005","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nn738","article-title":"TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination","volume":"4","author":"Arnett","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-2094-11-16","article-title":"Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G","volume":"11","author":"Asavapanumas","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0015","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00401-013-1204-8","article-title":"Unique neuromyelitis optica pathology produced in naive rats by intracerebral administration of NMO-IgG","volume":"127","author":"Asavapanumas","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0020","doi-asserted-by":"crossref","unstructured":"Asavapanumas N, Verkman AS. Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury. Acta Neuropathol. Commun. 2014;2:48.","DOI":"10.1186\/2051-5960-2-48"},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0025","first-page":"7","article-title":"Astrocytic functions and physiological reactions to injury: the potential to induce and\/or exacerbate neuronal dysfunction\u2014a forum position paper","volume":"19","author":"Aschner","year":"1998","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0030","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s00415-010-5863-2","article-title":"Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis","volume":"258","author":"Axelsson","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.nbd.2011.05.019","article-title":"The role of CXCR4 signaling in the migration of transplanted oligodendrocyte progenitors into the cerebral white matter","volume":"44","author":"Banisadr","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jneuroim.2006.05.003","article-title":"A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein","volume":"177","author":"Calderon","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0045","first-page":"64","article-title":"Biomarkers for neuromyelitis optica","volume":"440C","author":"Chang","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0050","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neuron.2014.06.010","article-title":"Glial development: the crossroads of regeneration and repair in the CNS","volume":"83","author":"Gallo","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0055","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jneuroim.2008.03.009","article-title":"Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay","volume":"196","author":"Hayakawa","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaut.2012.07.008","article-title":"Astrocytic autoantibody of neuromyelitis optica (NMO-IgG) binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arrays","volume":"40","author":"Iorio","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0065","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.leukres.2013.01.016","article-title":"Endogenous stromal cell-derived factor-1 (CXCL12) supports autonomous growth of acute myeloid leukemia cells","volume":"37","author":"Kim","year":"2013","journal-title":"Leuk. Res."},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pathophys.2010.04.008","article-title":"Neuromyelitis optica and opticospinal multiple sclerosis: mechanisms and pathogenesis","volume":"18","author":"Kira","year":"2011","journal-title":"Pathophysiology"},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0075","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.preteyeres.2013.03.001","article-title":"Optic neuritis in neuromyelitis optica","volume":"36","author":"Levin","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/bpa.12099","article-title":"The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica","volume":"24","author":"Lucchinetti","year":"2014","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0085","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbrc.2013.09.083","article-title":"TNF receptor 2 protects oligodendrocyte progenitor cells against oxidative stress","volume":"440","author":"Maier","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0090","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1084\/jem.20080730","article-title":"CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells","volume":"205","author":"Meiron","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12026-012-8282-x","article-title":"CXCL12 in control of neuroinflammation","volume":"52","author":"Momcilovic","year":"2012","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0100","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00401-012-1034-0","article-title":"Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS","volume":"124","author":"Patel","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0105","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1212\/WNL.0b013e3182152881","article-title":"Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab","volume":"76","author":"Pellkofer","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1476-9255-6-18","article-title":"TNF-alpha and IL-10 downregulation and marked oxidative stress in neuromyelitis optica","volume":"6","author":"Penton-Rol","year":"2009","journal-title":"J. Inflamm."},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0115","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1523\/JNEUROSCI.3742-14.2015","article-title":"Biomarkers of traumatic injury are transported from brain to blood via the glymphatic system","volume":"35","author":"Plog","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0120","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1212\/WNL.0000000000001126","article-title":"Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions","volume":"84","author":"Popescu","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2014.12.004","article-title":"Changes of CXCL12, CXCL14 and PDGF levels in the brain of patients with idiopathic demyelinating optic neuritis and neuromyelitis optica","volume":"279","author":"Chen","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","article-title":"Optic neuritis","volume":"13","author":"Toosy","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0135","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jocn.2012.12.022","article-title":"Neuromyelitis optica: concept, immunology and treatment","volume":"21","author":"Uzawa","year":"2014","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0140","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1007\/s00415-011-6384-3","article-title":"When is neuromyelitis optica diagnosed after disease onset?","volume":"259","author":"Uzawa","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0145","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cca.2013.03.020","article-title":"Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks","volume":"421","author":"Uzawa","year":"2013","journal-title":"Clinica Chim. Acta"},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2014.05.004","article-title":"NMO spectrum of disorders: a paradigm for astrocyte-targeting autoimmunity and its implications for MS and other CNS inflammatory diseases","author":"Vaknin-Dembinsky","year":"2014","journal-title":"J. Autoimmun"},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0155","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/bpa.12085","article-title":"Biology of AQP4 and anti-AQP4 antibody: therapeutic implications for NMO","volume":"23","author":"Verkman","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0160","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.neuroscience.2012.08.041","article-title":"Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis optica","volume":"226","author":"Wang","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0165","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/glia.20546","article-title":"Astrocytes\u2014friends or foes in multiple sclerosis?","volume":"55","author":"Williams","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0170","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0175","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0180","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0185","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/B978-0-444-52001-2.00025-X","article-title":"Neuromyelitis optica (Devic's syndrome)","volume":"122","author":"Wingerchuk","year":"2014","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.jneuroim.2015.10.005_bb0190","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12883-014-0162-7","article-title":"Neuromyelitis optica spectrum disorders without and with autoimmune diseases","volume":"14","author":"Zhang","year":"2014","journal-title":"BMC Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572815300539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572815300539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:26:00Z","timestamp":1759047960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572815300539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":38,"alternative-id":["S0165572815300539"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2015.10.005","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The poor recovery of neuromyelitis optica spectrum disorder is associated with a lower level of CXCL12 in the human brain","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2015.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}